Anthony Mauriello is a special counsel in the Corporate Practice Group in the firm’s San Diego office.

Mr. Mauriello’s practice covers a broad range of general corporate matters, including counseling public and privately-held companies regarding disclosure and reporting requirements, technology licensing, equity incentives, employee compensation and benefits and the formation of new businesses. Mr. Mauriello also represents clients in a broad range of transactional matters, including public offerings, public and private company mergers and acquisitions, corporate partnering and licensing transactions, spin-offs and venture capital financings. He is counsel to public and private companies in a broad range of industries, with a focus on the life sciences, high-technology, telecommunications, biotechnology and medical products industries.

Mr. Mauriello has an established track record of guiding emerging growth companies from incorporation and early stage financings through strategic exits such as initial public offerings and mergers and acquisitions.

He routinely advises public companies with respect to securities laws and SEC reporting obligations, disclosure issues and corporate governance matters. Representative past and current public company clients include: Deckers Outdoor Corporation, Ligand Pharmaceuticals, MaxLinear, Vital Therapies, Bridgepoint Education, TearLab Corporation, The Outdoor Channel, Response Biomedical, and International Business Machines.